The Editor's roundtable: cyclooxygenase-2 inhibitors and cardiovascular risk.

The Editor's roundtable: cyclooxygenase-2 inhibitors and cardiovascular risk. Am J Cardiol. 2005 Dec 01; 96(11):1589-604.

View in: PubMed